Vijay Kumar

Stock Analyst at Evercore ISI Group

(2.35)
# 2,549
Out of 4,896 analysts
224
Total ratings
45.38%
Success rate
-2.81%
Average return

Stocks Rated by Vijay Kumar

Zimmer Biomet Holdings
Jul 8, 2025
Maintains: In-Line
Price Target: $102$96
Current: $93.79
Upside: +2.36%
Thermo Fisher Scientific
Jul 8, 2025
Maintains: Outperform
Price Target: $500$480
Current: $434.86
Upside: +10.38%
Stryker
Jul 8, 2025
Maintains: Outperform
Price Target: $390$415
Current: $389.46
Upside: +6.56%
Revvity
Jul 8, 2025
Maintains: Outperform
Price Target: $116$115
Current: $101.50
Upside: +13.30%
Mettler-Toledo International
Jul 8, 2025
Maintains: Outperform
Price Target: $1,200$1,280
Current: $1,223.93
Upside: +4.58%
Medtronic
Jul 8, 2025
Maintains: Outperform
Price Target: $103$106
Current: $89.92
Upside: +17.88%
Intuitive Surgical
Jul 8, 2025
Maintains: In-Line
Price Target: $470$550
Current: $512.06
Upside: +7.41%
Illumina
Jul 8, 2025
Maintains: Outperform
Price Target: $116$128
Current: $99.25
Upside: +28.97%
Hologic
Jul 8, 2025
Maintains: In-Line
Price Target: $62$68
Current: $65.72
Upside: +3.47%
Exact Sciences
Jul 8, 2025
Maintains: Outperform
Price Target: $66$68
Current: $51.91
Upside: +31.00%
Maintains: In-Line
Price Target: $73$77
Current: $78.05
Upside: -1.35%
Maintains: Outperform
Price Target: $48$46
Current: $34.03
Upside: +35.17%
Maintains: Outperform
Price Target: $230$226
Current: $204.85
Upside: +10.32%
Maintains: Outperform
Price Target: $16$16
Current: $13.88
Upside: +15.27%
Maintains: Outperform
Price Target: $44$42
Current: $28.70
Upside: +46.34%
Maintains: In-Line
Price Target: $29$35
Current: $33.48
Upside: +4.54%
Maintains: Outperform
Price Target: $140$145
Current: $132.02
Upside: +9.83%
Maintains: In-Line
Price Target: $125$130
Current: $123.28
Upside: +5.45%
Maintains: In-Line
Price Target: $44$49
Current: $47.14
Upside: +3.95%
Maintains: In-Line
Price Target: $3
Current: $3.10
Upside: -3.23%
Maintains: Outperform
Price Target: $96$85
Current: $75.13
Upside: +13.14%
Maintains: Outperform
Price Target: $110$112
Current: $103.20
Upside: +8.53%
Maintains: Outperform
Price Target: $207$202
Current: $153.59
Upside: +31.52%
Upgrades: Outperform
Price Target: $18$30
Current: $17.60
Upside: +70.45%
Maintains: In-Line
Price Target: $335$355
Current: $352.91
Upside: +0.59%
Maintains: Outperform
Price Target: $52$56
Current: $38.03
Upside: +47.25%
Maintains: Outperform
Price Target: $120$160
Current: $87.52
Upside: +82.82%
Maintains: Outperform
Price Target: $286$290
Current: $175.97
Upside: +64.80%
Maintains: Outperform
Price Target: $28$27
Current: $13.58
Upside: +98.82%
Initiates: Outperform
Price Target: $7
Current: $0.77
Upside: +810.27%